FDA Inspection 1148556 — Martha L. Arellano, M.D.
The FDA completed an inspection of Martha L. Arellano, M.D. on Aug 5, 2021 in Atlanta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 5, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Atlanta, GA (United States)
Additional Details
Clinical Investigator (CI)